お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ペット用医薬品の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にペット用医薬品市場を分類しています。
本レポートでは世界のペット用医薬品市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Chopperlvya Animal Health、CAHIC、Animalcare Group、Parnell、Ringpu、Jinyu Group、Kyoritsu Seiyaku

レポートはペット用医薬品の主要生産者を調査し、主要地域や国の消費状況も提供します。ペット用医薬品の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Antiparasitic
    Biological Products
    Antibacterial
    Others

用途別の市場セグメント：
    Prevention
    Treatment

本レポートの詳細内容
本レポートは、世界のペット用医薬品市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてペット用医薬品市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のペット用医薬品生産量、成長率、市場シェアを調査している。

二. 消費面では、ペット用医薬品の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのペット用医薬品売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のペット用医薬品市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ペット用医薬品のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ペット用医薬品のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： ペット用医薬品の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるペット用医薬品の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章ペット用医薬品メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：ペット用医薬品の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：ペット用医薬品の主要メーカーの概要を提供し、製品の説明と仕様、ペット用医薬品の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ペット用医薬品の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Pet Pharmaceuticals market is projected to grow from US$ 18770 million in 2025 to US$ 28170 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
Pet pharmaceutical refers specifically to medicines given to pets. In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved. In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
The pet pharmaceuticals market is experiencing strong growth, driven by the rising trend of pet humanization, increasing pet ownership, and heightened awareness of animal health. As more people consider pets as part of the family, spending on veterinary care and pharmaceuticals has surged globally. Advancements in veterinary medicine have also contributed to the development of more targeted and effective drugs for chronic diseases, pain management, parasitic infections, and preventive care. Additionally, the growing elderly population and single households have led to higher demand for companion animals, further fueling the market. Pet insurance is becoming more widespread, especially in North America and Europe, making veterinary drugs more accessible and affordable to pet owners. These factors collectively boost the demand for both prescription and over-the-counter pet medications.
Despite promising growth, the pet pharmaceuticals market faces several challenges. Regulatory requirements for veterinary drugs are becoming stricter, increasing the time and cost needed for product development and approval. Additionally, counterfeit and low-quality medications, particularly in developing regions, can undermine the trust of veterinarians and pet owners. Limited availability of skilled veterinary professionals in some countries also affects the diagnosis and prescription of appropriate pharmaceutical treatments. Another barrier is the high cost of innovative pet drugs, which can deter adoption, especially among lower-income pet owners. Moreover, competition from alternative therapies and natural remedies is rising, presenting additional challenges for pharmaceutical companies to differentiate their products in an increasingly crowded marketplace.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
In terms of production side, this report researches the Pet Pharmaceuticals production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Pet Pharmaceuticals by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Pet Pharmaceuticals, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pet Pharmaceuticals, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pet Pharmaceuticals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Pharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pet Pharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pet Pharmaceuticals sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, etc.

Market Segmentation
By Company
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC
    Animalcare Group
    Parnell
    Ringpu
    Jinyu Group
    Kyoritsu Seiyaku

Segment by Type
    Antiparasitic
    Biological Products
    Antibacterial
    Others

Segment by Application
    Prevention
    Treatment

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Pet Pharmaceuticals production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Pet Pharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Pharmaceuticals sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
 Table 1. Global Pet Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antiparasitic
 Table 3. Key Players of Biological Products
 Table 4. Key Players of Antibacterial
 Table 5. Key Players of Others
 Table 6. Global Pet Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 9. Global Pet Pharmaceuticals Market Share by Region (2020-2031)
 Table 10. Market Trends
 Table 11. Market Drivers
 Table 12. Market Challenges
 Table 13. Market Restraints
 Table 14. Global Pet Pharmaceuticals Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pet Pharmaceuticals Market Share by Players (2020-2025)
 Table 16. Global Top Pet Pharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pharmaceuticals as of 2024)
 Table 17. Global Pet Pharmaceuticals Industry Ranking 2023 VS 2024
 Table 18. Global 5 Largest Players Market Share by Pet Pharmaceuticals Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pet Pharmaceuticals, Headquarters and Area Served
 Table 20. Global Key Players of Pet Pharmaceuticals, Product and Application
 Table 21. Global Key Players of Pet Pharmaceuticals, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pet Pharmaceuticals Revenue Market Share by Type (2020-2025)
 Table 25. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pet Pharmaceuticals Revenue Market Share by Type (2026-2031)
 Table 27. Global Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pet Pharmaceuticals Revenue Market Share by Application (2020-2025)
 Table 29. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pet Pharmaceuticals Revenue Market Share by Application (2026-2031)
 Table 31. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 32. North America Market Size by Application (2020-2031) & (US$ Million)
 Table 33. North America Pet Pharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 35. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 36. Europe Market Size by Application (2020-2031) & (US$ Million)
 Table 37. Europe Pet Pharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 39. China Market Size by Type (2020-2031) & (US$ Million)
 Table 40. China Market Size by Application (2020-2031) & (US$ Million)
 Table 41. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 42. Asia Market Size by Application (2020-2025) & (US$ Million)
 Table 43. Asia Pet Pharmaceuticals Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 45. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 46. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
 Table 47. Middle East, Africa, and Latin America Pet Pharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 49. Zoetis Company Details
 Table 50. Zoetis Business Overview
 Table 51. Zoetis Pet Pharmaceuticals Product
 Table 52. Zoetis Revenue (2020-2025) & (US$ Million)
 Table 53. Zoetis Recent Development
 Table 54. Boehringer Ingelheim Company Details
 Table 55. Boehringer Ingelheim Business Overview
 Table 56. Boehringer Ingelheim Pet Pharmaceuticals Product
 Table 57. Boehringer Ingelheim Revenue (2020-2025) & (US$ Million)
 Table 58. Boehringer Ingelheim Recent Development
 Table 59. Merck Company Details
 Table 60. Merck Business Overview
 Table 61. Merck Pet Pharmaceuticals Product
 Table 62. Merck Revenue (2020-2025) & (US$ Million)
 Table 63. Merck Recent Development
 Table 64. Elanco Company Details
 Table 65. Elanco Business Overview
 Table 66. Elanco Pet Pharmaceuticals Product
 Table 67. Elanco Revenue (2020-2025) & (US$ Million)
 Table 68. Elanco Recent Development
 Table 69. Virbac Company Details
 Table 70. Virbac Business Overview
 Table 71. Virbac Pet Pharmaceuticals Product
 Table 72. Virbac Revenue (2020-2025) & (US$ Million)
 Table 73. Virbac Recent Development
 Table 74. Dechra Veterinary Products Company Details
 Table 75. Dechra Veterinary Products Business Overview
 Table 76. Dechra Veterinary Products Pet Pharmaceuticals Product
 Table 77. Dechra Veterinary Products Revenue (2020-2025) & (US$ Million)
 Table 78. Dechra Veterinary Products Recent Development
 Table 79. Ceva Company Details
 Table 80. Ceva Business Overview
 Table 81. Ceva Pet Pharmaceuticals Product
 Table 82. Ceva Revenue (2020-2025) & (US$ Million)
 Table 83. Ceva Recent Development
 Table 84. Vetoquinol Company Details
 Table 85. Vetoquinol Business Overview
 Table 86. Vetoquinol Pet Pharmaceuticals Product
 Table 87. Vetoquinol Revenue (2020-2025) & (US$ Million)
 Table 88. Vetoquinol Recent Development
 Table 89. Ouro Fino Saude Company Details
 Table 90. Ouro Fino Saude Business Overview
 Table 91. Ouro Fino Saude Pet Pharmaceuticals Product
 Table 92. Ouro Fino Saude Revenue (2020-2025) & (US$ Million)
 Table 93. Ouro Fino Saude Recent Development
 Table 94. Norbrook Company Details
 Table 95. Norbrook Business Overview
 Table 96. Norbrook Pet Pharmaceuticals Product
 Table 97. Norbrook Revenue (2020-2025) & (US$ Million)
 Table 98. Norbrook Recent Development
 Table 99. Jindun Company Details
 Table 100. Jindun Business Overview
 Table 101. Jindun Pet Pharmaceuticals Product
 Table 102. Jindun Revenue (2020-2025) & (US$ Million)
 Table 103. Jindun Recent Development
 Table 104. Chopperlvya Animal Health Company Details
 Table 105. Chopperlvya Animal Health Business Overview
 Table 106. Chopperlvya Animal Health Pet Pharmaceuticals Product
 Table 107. Chopperlvya Animal Health Revenue (2020-2025) & (US$ Million)
 Table 108. Chopperlvya Animal Health Recent Development
 Table 109. CAHIC Company Details
 Table 110. CAHIC Business Overview
 Table 111. CAHIC Pet Pharmaceuticals Product
 Table 112. CAHIC Revenue (2020-2025) & (US$ Million)
 Table 113. CAHIC Recent Development
 Table 114. Animalcare Group Company Details
 Table 115. Animalcare Group Business Overview
 Table 116. Animalcare Group Pet Pharmaceuticals Product
 Table 117. Animalcare Group Revenue (2020-2025) & (US$ Million)
 Table 118. Animalcare Group Recent Development
 Table 119. Parnell Company Details
 Table 120. Parnell Business Overview
 Table 121. Parnell Pet Pharmaceuticals Product
 Table 122. Parnell Revenue (2020-2025) & (US$ Million)
 Table 123. Parnell Recent Development
 Table 124. Ringpu Company Details
 Table 125. Ringpu Business Overview
 Table 126. Ringpu Pet Pharmaceuticals Product
 Table 127. Ringpu Revenue (2020-2025) & (US$ Million)
 Table 128. Ringpu Recent Development
 Table 129. Jinyu Group Company Details
 Table 130. Jinyu Group Business Overview
 Table 131. Jinyu Group Pet Pharmaceuticals Product
 Table 132. Jinyu Group Revenue (2020-2025) & (US$ Million)
 Table 133. Jinyu Group Recent Development
 Table 134. Kyoritsu Seiyaku Company Details
 Table 135. Kyoritsu Seiyaku Business Overview
 Table 136. Kyoritsu Seiyaku Pet Pharmaceuticals Product
 Table 137. Kyoritsu Seiyaku Revenue (2020-2025) & (US$ Million)
 Table 138. Kyoritsu Seiyaku Recent Development
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Pet Pharmaceuticals Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global Pet Pharmaceuticals Market Share by Type: 2024 VS 2031
 Figure 3. Antiparasitic Features
 Figure 4. Biological Products Features
 Figure 5. Antibacterial Features
 Figure 6. Others Features
 Figure 7. Global Pet Pharmaceuticals Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Global Pet Pharmaceuticals Market Share by Application: 2024 VS 2031
 Figure 9. Prevention Case Studies
 Figure 10. Treatment Case Studies
 Figure 11. Pet Pharmaceuticals Report Years Considered
 Figure 12. Global Pet Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Pet Pharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pet Pharmaceuticals Market Share by Region: 2024 VS 2031
 Figure 15. Global Pet Pharmaceuticals Market Share by Players in 2024
 Figure 16. Global Top Pet Pharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pharmaceuticals as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Pet Pharmaceuticals Revenue in 2024
 Figure 18. North America Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Pet Pharmaceuticals Market Share by Type (2020-2031)
 Figure 20. North America Pet Pharmaceuticals Market Share by Application (2020-2031)
 Figure 21. North America Pet Pharmaceuticals Market Share by Country (2020-2031)
 Figure 22. United States Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pet Pharmaceuticals Market Share by Type (2020-2031)
 Figure 26. Europe Pet Pharmaceuticals Market Share by Application (2020-2031)
 Figure 27. Europe Pet Pharmaceuticals Market Share by Country (2020-2031)
 Figure 28. Germany Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. China Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. China Pet Pharmaceuticals Market Share by Type (2020-2031)
 Figure 36. China Pet Pharmaceuticals Market Share by Application (2020-2031)
 Figure 37. Asia Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia Pet Pharmaceuticals Market Share by Type (2020-2031)
 Figure 39. Asia Pet Pharmaceuticals Market Share by Application (2020-2031)
 Figure 40. Asia Pet Pharmaceuticals Market Share by Region (2020-2031)
 Figure 41. Japan Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. India Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Australia Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East, Africa, and Latin America Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East, Africa, and Latin America Pet Pharmaceuticals Market Share by Type (2020-2031)
 Figure 49. Middle East, Africa, and Latin America Pet Pharmaceuticals Market Share by Application (2020-2031)
 Figure 50. Middle East, Africa, and Latin America Pet Pharmaceuticals Market Share by Country (2020-2031)
 Figure 51. Brazil Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Mexico Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Turkey Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Israel Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. GCC Countries Pet Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. Zoetis Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 58. Boehringer Ingelheim Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 59. Merck Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 60. Elanco Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 61. Virbac Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 62. Dechra Veterinary Products Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 63. Ceva Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 64. Vetoquinol Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 65. Ouro Fino Saude Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 66. Norbrook Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 67. Jindun Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 68. Chopperlvya Animal Health Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 69. CAHIC Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 70. Animalcare Group Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 71. Parnell Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 72. Ringpu Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 73. Jinyu Group Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 74. Kyoritsu Seiyaku Revenue Growth Rate in Pet Pharmaceuticals Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed